| (State of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
| (Address of principal executive offices) | (Zip Code) | ||||
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
The (Nasdaq Global Select Market) | ||||||||||||||

| Three months ended | |||||||||||||||||||||||||||||
| (in millions, except per-share data) | 3/31/2025 | 3/31/2024 | Change(1) | 12/31/2024 | Change(1) | ||||||||||||||||||||||||
| U.S. GAAP basis | |||||||||||||||||||||||||||||
| Investment advisory fees | $ | 1,598.4 | $ | 1,536.4 | 4.0 | % | $ | 1,667.2 | (4.1) | % | |||||||||||||||||||
Performance-based advisory fees(2) | $ | 10.4 | $ | 17.6 | (40.9) | % | $ | 19.3 | (46.1) | % | |||||||||||||||||||
Capital allocation-based income(3) | $ | (1.2) | $ | 47.1 | n/m | $ | (5.2) | n/m | |||||||||||||||||||||
| Net revenues | $ | 1,763.9 | $ | 1,750.2 | 0.8 | % | $ | 1,824.5 | (3.3) | % | |||||||||||||||||||
| Operating expenses | $ | 1,167.6 | $ | 1,163.6 | 0.3 | % | $ | 1,256.1 | (7.0) | % | |||||||||||||||||||
| Net operating income | $ | 596.3 | $ | 586.6 | 1.7 | % | $ | 568.4 | 4.9 | % | |||||||||||||||||||
| Non-operating income (loss) | $ | 70.7 | $ | 188.9 | n/m | $ | 4.6 | n/m | |||||||||||||||||||||
| Net income - T. Rowe Price Group, Inc. | $ | 490.5 | $ | 573.8 | (14.5) | % | $ | 439.9 | 11.5 | % | |||||||||||||||||||
| Diluted earnings per common share | $ | 2.15 | $ | 2.49 | (13.7) | % | $ | 1.92 | 12.0 | % | |||||||||||||||||||
Adjusted basis(4) | |||||||||||||||||||||||||||||
| Operating expenses | $ | 1,135.1 | $ | 1,071.4 | 5.9 | % | $ | 1,222.6 | (7.2) | % | |||||||||||||||||||
| Operating expenses, excluding accrued carried interest related compensation | $ | 1,131.2 | $ | 1,052.9 | 7.4 | % | $ | 1,218.7 | (7.2) | % | |||||||||||||||||||
| Net operating income | $ | 640.6 | $ | 692.4 | (7.5) | % | $ | 620.2 | 3.3 | % | |||||||||||||||||||
| Non-operating income (loss) | $ | 35.5 | $ | 28.5 | 24.6 | % | $ | 34.3 | 3.5 | % | |||||||||||||||||||
| Net income - T. Rowe Price Group, Inc. | $ | 509.3 | $ | 548.5 | (7.1) | % | $ | 484.8 | 5.1 | % | |||||||||||||||||||
| Diluted earnings per common share | $ | 2.23 | $ | 2.38 | (6.3) | % | $ | 2.12 | 5.2 | % | |||||||||||||||||||
Assets under management (in billions) | |||||||||||||||||||||||||||||
| Average assets under management | $ | 1,620.3 | $ | 1,484.4 | 9.2 | % | $ | 1,638.6 | (1.1) | % | |||||||||||||||||||
| Ending assets under management | $ | 1,566.3 | $ | 1,542.2 | 1.6 | % | $ | 1,606.6 | (2.5) | % | |||||||||||||||||||
Investment advisory annualized effective fee rate (EFR) (in bps) | |||||||||||||||||||||||||||||
| EFR without performance-based fees | 40.0 | 41.6 | (1.6) | 40.5 | (0.5) | ||||||||||||||||||||||||
| EFR with performance-based fees | 40.3 | 42.1 | (1.8) | 40.9 | (0.6) | ||||||||||||||||||||||||
Three months ended 3/31/2025 | |||||||||||||||||||||||||||||
| (in billions) | Equity | Fixed income, including money market | Multi-asset(1) | Alternatives(2) | Total | ||||||||||||||||||||||||
| Assets under management at beginning of period | $ | 829.7 | $ | 188.1 | $ | 536.0 | $ | 52.8 | $ | 1,606.6 | |||||||||||||||||||
| Net cash flows prior to manager-driven distributions | (19.2) | 5.4 | 5.5 | 0.4 | (7.9) | ||||||||||||||||||||||||
| Manager-driven distributions | — | — | — | (0.7) | (0.7) | ||||||||||||||||||||||||
| Net cash flows | (19.2) | 5.4 | 5.5 | (0.3) | (8.6) | ||||||||||||||||||||||||
Net market appreciation (depreciation) and income(3) | (37.1) | 2.2 | 2.9 | 0.3 | (31.7) | ||||||||||||||||||||||||
| Change during the period | (56.3) | 7.6 | 8.4 | — | (40.3) | ||||||||||||||||||||||||
Assets under management at March 31, 2025 | $ | 773.4 | $ | 195.7 | $ | 544.4 | $ | 52.8 | $ | 1,566.3 | |||||||||||||||||||
| Three months ended | |||||||||||||||||||||||||||||
| (in millions) | 3/31/2025 | 3/31/2024 | Change | 12/31/2024 | Change | ||||||||||||||||||||||||
| Investment advisory fees | |||||||||||||||||||||||||||||
| Equity | $ | 959.2 | $ | 932.5 | 2.9 | % | $ | 1,006.2 | (4.7) | % | |||||||||||||||||||
| Fixed income, including money market | 103.6 | 100.2 | 3.4 | % | 106.2 | (2.4) | % | ||||||||||||||||||||||
| Multi-asset | 454.7 | 429.7 | 5.8 | % | 473.8 | (4.0) | % | ||||||||||||||||||||||
| Alternatives | 80.9 | 74.0 | 9.3 | % | 81.0 | (0.1) | % | ||||||||||||||||||||||
| Total investment advisory fees | 1,598.4 | 1,536.4 | 4.0 | % | 1,667.2 | (4.1) | % | ||||||||||||||||||||||
Performance-based advisory fees(1) | 10.4 | 17.6 | (40.9) | % | 19.3 | (46.1) | % | ||||||||||||||||||||||
Capital allocation-based income(2) | (1.2) | 47.1 | n/m | (5.2) | n/m | ||||||||||||||||||||||||
| Administrative, distribution, services, and other fees | 156.3 | 149.1 | 4.8 | % | 143.2 | 9.1 | % | ||||||||||||||||||||||
| Net revenues | $ | 1,763.9 | $ | 1,750.2 | 0.8 | % | $ | 1,824.5 | (3.3) | % | |||||||||||||||||||
| Average AUM (in billions): | |||||||||||||||||||||||||||||
| Equity | $ | 826.3 | $ | 770.4 | 7.3 | % | $ | 842.7 | (1.9) | % | |||||||||||||||||||
| Fixed income, including money market | 191.6 | 169.5 | 13.0 | % | 186.9 | 2.5 | % | ||||||||||||||||||||||
| Multi-asset | 549.7 | 497.0 | 10.6 | % | 556.3 | (1.2) | % | ||||||||||||||||||||||
| Alternatives | 52.7 | 47.5 | 10.9 | % | 52.7 | — | % | ||||||||||||||||||||||
| Average AUM | $ | 1,620.3 | $ | 1,484.4 | 9.2 | % | $ | 1,638.6 | (1.1) | % | |||||||||||||||||||
| Investment advisory annualized effective fee rate (bps) | 40.0 | 41.6 | (1.6) | 40.5 | (0.5) | ||||||||||||||||||||||||
| Investment advisory annualized effective fee rate, including performance-based fees (bps) | 40.3 | 42.1 | (1.8) | 40.9 | (0.6) | ||||||||||||||||||||||||
| Three months ended | |||||||||||||||||||||||||||||
| (in millions) | 3/31/2025 | 3/31/2024 | Change (1) | 12/31/2024 | Change (1) | ||||||||||||||||||||||||
| Compensation, benefits, and related costs | $ | 657.9 | $ | 629.3 | 4.5 | % | $ | 705.4 | (6.7) | % | |||||||||||||||||||
| Acquisition-related retention agreements | 14.2 | 13.5 | 5.2 | % | 14.2 | — | % | ||||||||||||||||||||||
Capital allocation-based income compensation(2) | (0.4) | 13.2 | n/m | (3.4) | n/m | ||||||||||||||||||||||||
| Market-related change in deferred compensation liabilities | (7.2) | 53.0 | n/m | (6.7) | n/m | ||||||||||||||||||||||||
| Total compensation and related costs | 664.5 | 709.0 | (6.3) | % | 709.5 | (6.3) | % | ||||||||||||||||||||||
| Distribution and servicing | 93.6 | 81.9 | 14.3 | % | 92.9 | 0.8 | % | ||||||||||||||||||||||
| Advertising and promotion | 26.1 | 25.3 | 3.2 | % | 50.2 | (48.0) | % | ||||||||||||||||||||||
| Product and recordkeeping related costs | 83.8 | 75.0 | 11.7 | % | 74.5 | 12.5 | % | ||||||||||||||||||||||
| Technology, occupancy, and facility costs | 167.6 | 149.9 | 11.8 | % | 169.3 | (1.0) | % | ||||||||||||||||||||||
| General, administrative, and other | 103.3 | 92.6 | 11.6 | % | 128.3 | (19.5) | % | ||||||||||||||||||||||
| Acquisition-related amortization and impairment costs | 28.7 | 29.9 | (4.0) | % | 31.4 | (8.6) | % | ||||||||||||||||||||||
| Total operating expenses | $ | 1,167.6 | $ | 1,163.6 | 0.3 | % | $ | 1,256.1 | (7.0) | % | |||||||||||||||||||
Total adjusted operating expenses(3) | $ | 1,135.1 | $ | 1,071.4 | 5.9 | % | $ | 1,222.6 | (7.2) | % | |||||||||||||||||||
| (in millions) | Three months ended | ||||||||||||||||
| 3/31/2025 | 3/31/2024 | 12/31/2024 | |||||||||||||||
| Net gains (losses) from non-consolidated investment products | |||||||||||||||||
| Cash and discretionary investments | |||||||||||||||||
| Dividend income | $ | 30.4 | $ | 27.8 | $ | 39.8 | |||||||||||
| Market-related gains (losses) and equity in earnings (losses) | 4.2 | 0.2 | (1.4) | ||||||||||||||
| Total net gains (losses) from cash and discretionary investments | 34.6 | 28.0 | 38.4 | ||||||||||||||
| Seed capital investments | |||||||||||||||||
| Dividend income | 0.2 | — | 1.6 | ||||||||||||||
| Market-related gains (losses) and equity in earnings (losses) | (11.3) | 23.5 | 1.9 | ||||||||||||||
| Net gains (losses) recognized upon deconsolidation | — | — | 0.2 | ||||||||||||||
| Investments used to hedge deferred compensation liabilities | (10.7) | 49.7 | (9.2) | ||||||||||||||
| Total net gains (losses) from non-consolidated investment products | 12.8 | 101.2 | 32.9 | ||||||||||||||
| Other investment income (loss) | 19.1 | 20.3 | 11.8 | ||||||||||||||
| Net gains (losses) on investments | 31.9 | 121.5 | 44.7 | ||||||||||||||
| Net gains (losses) on consolidated investment products | 31.9 | 72.3 | (36.4) | ||||||||||||||
| Other gains (losses), including foreign currency gains (losses) | 6.9 | (4.9) | (3.7) | ||||||||||||||
| Non-operating income (loss) | $ | 70.7 | $ | 188.9 | $ | 4.6 | |||||||||||
Adjusted non-operating income (loss)(1) | $ | 35.5 | $ | 28.5 | $ | 34.3 | |||||||||||
| Three months ended | |||||||||||
| 3/31/2025 | 3/31/2024 | ||||||||||
| Statutory U.S. federal income tax rate | 21.0 | % | 21.0 | % | |||||||
State income taxes for current year, net of federal income tax benefits(1) | 2.8 | 2.5 | |||||||||
Net (income) losses attributable to redeemable non-controlling interests(2) | (0.5) | (0.5) | |||||||||
| Net excess tax losses (benefits) from stock-based compensation plans activity | (0.3) | (0.3) | |||||||||
| Valuation allowances | 0.4 | 0.5 | |||||||||
| Other items | 0.9 | 0.3 | |||||||||
| Effective income tax rate | 24.3 | % | 23.5 | % | |||||||
| Adjusted effective income tax rate | 24.7 | % | 23.9 | % | |||||||
| Public Relations | Investor Relations | ||||||||||
| Lauren Dear | Linsley Carruth | ||||||||||
| 410-577-5009 | 410-345-3717 | ||||||||||
| [email protected] | [email protected] | ||||||||||
| Unaudited Consolidated Statements of Income | ||||||||||||||||||||
| (in millions, except per-share amounts) | ||||||||||||||||||||
| Three months ended | ||||||||||||||||||||
| Revenues | 3/31/2025 | 3/31/2024 | 12/31/2024 | |||||||||||||||||
| Investment advisory fees | $ | 1,598.4 | $ | 1,536.4 | $ | 1,667.2 | ||||||||||||||
Performance-based advisory fees(1) | 10.4 | 17.6 | 19.3 | |||||||||||||||||
| Capital allocation-based income | (1.2) | 47.1 | (5.2) | |||||||||||||||||
| Administrative, distribution, services, and other fees | 156.3 | 149.1 | 143.2 | |||||||||||||||||
| Net revenues | 1,763.9 | 1,750.2 | 1,824.5 | |||||||||||||||||
| Operating expenses | ||||||||||||||||||||
| Compensation, benefits, and related costs | 657.9 | 629.3 | 705.4 | |||||||||||||||||
| Acquisition-related retention agreements | 14.2 | 13.5 | 14.2 | |||||||||||||||||
| Capital allocation-based income compensation | (0.4) | 13.2 | (3.4) | |||||||||||||||||
| Market-related change in deferred compensation liabilities | (7.2) | 53.0 | (6.7) | |||||||||||||||||
| Total compensation and related costs | 664.5 | 709.0 | 709.5 | |||||||||||||||||
| Distribution and servicing | 93.6 | 81.9 | 92.9 | |||||||||||||||||
| Advertising and promotion | 26.1 | 25.3 | 50.2 | |||||||||||||||||
| Product and recordkeeping related costs | 83.8 | 75.0 | 74.5 | |||||||||||||||||
| Technology, occupancy, and facility costs | 167.6 | 149.9 | 169.3 | |||||||||||||||||
| General, administrative, and other | 103.3 | 92.6 | 128.3 | |||||||||||||||||
| Acquisition-related amortization and impairment costs | 28.7 | 29.9 | 31.4 | |||||||||||||||||
| Total operating expenses | 1,167.6 | 1,163.6 | 1,256.1 | |||||||||||||||||
| Net operating income | 596.3 | 586.6 | 568.4 | |||||||||||||||||
| Non-operating income (loss) | ||||||||||||||||||||
| Net gains (losses) on investments | 31.9 | 121.5 | 44.7 | |||||||||||||||||
| Net gains (losses) on consolidated investment products | 31.9 | 72.3 | (36.4) | |||||||||||||||||
| Other gains (losses), including foreign currency gains (losses) | 6.9 | (4.9) | (3.7) | |||||||||||||||||
| Total non-operating income (loss) | 70.7 | 188.9 | 4.6 | |||||||||||||||||
| Income before income taxes | 667.0 | 775.5 | 573.0 | |||||||||||||||||
| Provision for income taxes | 161.9 | 182.1 | 156.3 | |||||||||||||||||
| Net income | 505.1 | 593.4 | 416.7 | |||||||||||||||||
| Less: net income (loss) attributable to redeemable non-controlling interests | 14.6 | 19.6 | (23.2) | |||||||||||||||||
| Net income attributable to T. Rowe Price Group, Inc. | 490.5 | 573.8 | 439.9 | |||||||||||||||||
| Less: net income allocated to outstanding restricted stock and stock unit holders | 12.4 | 15.8 | 11.6 | |||||||||||||||||
| Net income allocated to T. Rowe Price common stockholders | $ | 478.1 | $ | 558.0 | $ | 428.3 | ||||||||||||||
| Earnings per share | ||||||||||||||||||||
| Basic | $ | 2.15 | $ | 2.50 | $ | 1.93 | ||||||||||||||
| Diluted | $ | 2.15 | $ | 2.49 | $ | 1.92 | ||||||||||||||
| Weighted-average common shares | ||||||||||||||||||||
| Outstanding | 222.3 | 223.6 | 222.4 | |||||||||||||||||
| Outstanding assuming dilution | 222.6 | 224.2 | 222.8 | |||||||||||||||||
Summary of Adjusted Basis(2) | Three months ended | |||||||||||||||||||
| (in millions, except per-share data) | 3/31/2025 | 3/31/2024 | 12/31/2024 | |||||||||||||||||
| Operating expenses | $ | 1,135.1 | $ | 1,071.4 | $ | 1,222.6 | ||||||||||||||
| Operating expenses, excluding accrued carried interest related compensation | $ | 1,131.2 | $ | 1,052.9 | $ | 1,218.7 | ||||||||||||||
| Net operating income | $ | 640.6 | $ | 692.4 | $ | 620.2 | ||||||||||||||
| Non-operating income (loss) | $ | 35.5 | $ | 28.5 | $ | 34.3 | ||||||||||||||
| Net income attributable to T. Rowe Price | $ | 509.3 | $ | 548.5 | $ | 484.8 | ||||||||||||||
| Diluted earnings per common share | $ | 2.23 | $ | 2.38 | $ | 2.12 | ||||||||||||||
| Three months ended | |||||||||||||||||||||||
| 3/31/2025 | |||||||||||||||||||||||
(in millions) | Cash flow attributable to T. Rowe Price | Cash flow attributable to consolidated investment products | Elims | As reported | |||||||||||||||||||
| Cash flows from operating activities | |||||||||||||||||||||||
| Net income (loss) | $ | 490.5 | $ | 29.4 | $ | (14.8) | $ | 505.1 | |||||||||||||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities | |||||||||||||||||||||||
| Depreciation, amortization and impairments of property, equipment and software | 63.6 | — | — | 63.6 | |||||||||||||||||||
| Amortization and impairment of acquisition-related assets and retention agreements | 49.0 | — | — | 49.0 | |||||||||||||||||||
| Stock-based compensation expense | 50.3 | — | — | 50.3 | |||||||||||||||||||
| Net (gains) losses recognized on investments | (23.1) | — | 14.8 | (8.3) | |||||||||||||||||||
| Net investments in investment products used to economically hedge deferred compensation liabilities | 45.9 | — | — | 45.9 | |||||||||||||||||||
| Net change in trading securities held by consolidated investment products | — | (163.0) | — | (163.0) | |||||||||||||||||||
| Other changes | 95.7 | (3.5) | (1.9) | 90.3 | |||||||||||||||||||
| Net cash provided by (used in) operating activities | 771.9 | (137.1) | (1.9) | 632.9 | |||||||||||||||||||
| Net cash provided by (used in) investing activities | (95.6) | 3.7 | 44.1 | (47.8) | |||||||||||||||||||
| Net cash provided by (used in) financing activities | (489.4) | 120.2 | (42.2) | (411.4) | |||||||||||||||||||
| Effect of exchange rate changes on cash and cash equivalents of consolidated investment products | — | 0.9 | — | 0.9 | |||||||||||||||||||
| Net change in cash and cash equivalents during the period | 186.9 | (12.3) | — | 174.6 | |||||||||||||||||||
| Cash and cash equivalents at beginning of the year | 2,649.8 | 63.1 | — | 2,712.9 | |||||||||||||||||||
| Cash and cash equivalents at end of the period | $ | 2,836.7 | $ | 50.8 | $ | — | $ | 2,887.5 | |||||||||||||||
| Unaudited Condensed Consolidated Balance Sheet Information | As of | ||||||||||
| (in millions) | 3/31/2025 | 12/31/2024 | |||||||||
| Cash and cash equivalents | $ | 2,836.7 | $ | 2,649.8 | |||||||
| Accounts receivable and accrued revenue | 934.6 | 877.4 | |||||||||
| Investments | 3,240.3 | 3,000.5 | |||||||||
| Assets of consolidated investment products | 1,794.4 | 2,044.0 | |||||||||
| Operating lease assets | 421.3 | 226.8 | |||||||||
| Property, equipment and software, net | 995.5 | 977.0 | |||||||||
| Goodwill and intangible assets | 2,986.5 | 3,010.9 | |||||||||
| Other assets | 784.4 | 685.6 | |||||||||
| Total assets | 13,993.7 | 13,472.0 | |||||||||
| Deferred compensation liabilities | 976.9 | 1,020.7 | |||||||||
Total other liabilities, includes $42.0 at March 31, 2025, and $62.1 at December 31, 2024, from consolidated investment products | 1,484.5 | 1,001.2 | |||||||||
| Non-controlling interests* | 1,137.6 | 1,104.7 | |||||||||
Stockholders' equity attributable to T. Rowe Price Group, Inc., 221.1 common shares outstanding at March 31, 2025 and 223.0 common shares outstanding at December 31, 2024 | $ | 10,394.7 | $ | 10,345.4 | |||||||
| Investments in affiliated private investment funds - carried interest | Three months ended | ||||||||||||||||
| (in millions) | 3/31/2025 | 3/31/2024 | 12/31/2024 | ||||||||||||||
| Balance at beginning of period | $ | 426.9 | $ | 519.9 | $ | 499.7 | |||||||||||
| Capital allocation-based income: | |||||||||||||||||
| Change in accrued carried interest | 9.2 | 59.5 | 12.5 | ||||||||||||||
| Acquisition-related amortization and impairments | (10.4) | (12.4) | (17.7) | ||||||||||||||
| Net distributions | (43.1) | (52.7) | (67.6) | ||||||||||||||
Balance at end of period | $ | 382.6 | $ | 514.3 | $ | 426.9 | |||||||||||
| Non-controlling interests (NCI) in consolidated entities | Three months ended | ||||||||||||||||
| (in millions) | 3/31/2025 | 3/31/2024 | 12/31/2024 | ||||||||||||||
| Balance at beginning of period | $ | 160.7 | $ | 192.0 | $ | 203.4 | |||||||||||
| Capital allocation-based income compensation: | |||||||||||||||||
| Change in accrued carried interest compensation | 3.9 | 18.5 | 3.9 | ||||||||||||||
| Acquisition-related amortization and impairments | (4.3) | (5.3) | (7.3) | ||||||||||||||
| Net contributions (distributions) | 0.1 | 0.2 | (39.3) | ||||||||||||||
Balance at end of period | $ | 160.4 | $ | 205.4 | $ | 160.7 | |||||||||||
Three months ended 3/31/2025 | |||||||||||||||||||||||||||||||||||
| Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(5) | Net income attributable to T. Rowe Price Group, Inc. | Diluted earnings per share(6) | ||||||||||||||||||||||||||||||
| U.S. GAAP Basis (FS line item) | $ | 1,167.6 | $ | 596.3 | $ | 70.7 | $ | 161.9 | $ | 490.5 | $ | 2.15 | |||||||||||||||||||||||
| Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
| Acquisition-related: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) | 4.3 | 6.1 | — | 1.2 | 4.9 | 0.02 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) | (14.2) | 14.2 | — | 3.0 | 11.2 | 0.05 | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) | (28.7) | 28.7 | — | 5.9 | 22.8 | 0.10 | |||||||||||||||||||||||||||||
| Total acquisition-related | (38.6) | 49.0 | — | 10.1 | 38.9 | 0.17 | |||||||||||||||||||||||||||||
Deferred compensation liabilities(2) (Compensation and related costs) | 7.2 | (7.2) | 10.7 | 0.7 | 2.8 | 0.01 | |||||||||||||||||||||||||||||
Consolidated investment products(3) | (1.1) | 2.5 | (31.9) | (3.1) | (11.7) | (0.05) | |||||||||||||||||||||||||||||
Other non-operating income(4) | — | — | (14.0) | (2.8) | (11.2) | (0.05) | |||||||||||||||||||||||||||||
| Adjusted Non-GAAP Basis | $ | 1,135.1 | $ | 640.6 | $ | 35.5 | $ | 166.8 | $ | 509.3 | $ | 2.23 | |||||||||||||||||||||||
Three months ended 3/31/2024 | |||||||||||||||||||||||||||||||||||
| Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(5) | Net income attributable to T. Rowe Price Group, Inc. | Diluted earnings per share(6) | ||||||||||||||||||||||||||||||
| U.S. GAAP Basis (FS line item) | $ | 1,163.6 | $ | 586.6 | $ | 188.9 | $ | 182.1 | $ | 573.8 | $ | 2.49 | |||||||||||||||||||||||
| Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
| Acquisition-related: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) | 5.3 | 7.1 | — | 2.0 | 5.1 | 0.02 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) | (13.5) | 13.5 | — | 3.8 | 9.7 | 0.04 | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) | (29.9) | 29.9 | — | 8.3 | 21.6 | 0.10 | |||||||||||||||||||||||||||||
| Total acquisition-related | (38.1) | 50.5 | — | 14.1 | 36.4 | 0.16 | |||||||||||||||||||||||||||||
Deferred compensation liabilities(2) (Compensation and related costs) | (53.0) | 53.0 | (49.7) | 0.9 | 2.4 | 0.01 | |||||||||||||||||||||||||||||
Consolidated investment products(3) | (1.1) | 2.3 | (72.3) | (14.0) | (36.4) | (0.16) | |||||||||||||||||||||||||||||
Other non-operating income(4) | — | — | (38.4) | (10.7) | (27.7) | (0.12) | |||||||||||||||||||||||||||||
| Adjusted Non-GAAP Basis | $ | 1,071.4 | $ | 692.4 | $ | 28.5 | $ | 172.4 | $ | 548.5 | $ | 2.38 | |||||||||||||||||||||||
Three months ended 12/31/2024 | |||||||||||||||||||||||||||||||||||
| Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(5) | Net income attributable to T. Rowe Price Group, Inc. | Diluted earnings per share(6) | ||||||||||||||||||||||||||||||
| U.S. GAAP Basis (FS line item) | $ | 1,256.1 | $ | 568.4 | $ | 4.6 | $ | 156.3 | $ | 439.9 | $ | 1.92 | |||||||||||||||||||||||
| Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
| Acquisition-related: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) | 7.3 | 10.4 | — | 2.4 | 8.0 | 0.04 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) | (14.2) | 14.2 | — | 3.3 | 10.9 | 0.04 | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) | (31.4) | 31.4 | — | 7.2 | 24.2 | 0.11 | |||||||||||||||||||||||||||||
| Total acquisition-related | (38.3) | 56.0 | — | 12.9 | 43.1 | 0.19 | |||||||||||||||||||||||||||||
Deferred compensation liabilities(2) (Compensation and related costs) | 6.7 | (6.7) | 9.2 | 0.6 | 1.9 | 0.01 | |||||||||||||||||||||||||||||
Consolidated investment products(3) | (1.9) | 2.5 | 36.4 | 3.6 | 12.1 | 0.05 | |||||||||||||||||||||||||||||
Other non-operating income(4) | — | — | (15.9) | (3.7) | (12.2) | (0.05) | |||||||||||||||||||||||||||||
| Adjusted Non-GAAP Basis | $ | 1,222.6 | $ | 620.2 | $ | 34.3 | $ | 169.7 | $ | 484.8 | $ | 2.12 | |||||||||||||||||||||||
| Three months ended | |||||||||||||||||
| 3/31/2025 | 3/31/2024 | 12/31/2024 | |||||||||||||||
| Adjusted net income attributable to T. Rowe Price | $ | 509.3 | $ | 548.5 | $ | 484.8 | |||||||||||
| Less: adjusted net income allocated to outstanding restricted stock and stock unit holders | 12.9 | 15.2 | 12.7 | ||||||||||||||
| Adjusted net income allocated to common stockholders | $ | 496.4 | $ | 533.3 | $ | 472.1 | |||||||||||